Based on this pilot study of the malaria TAC, future design alterations could include more genotyping loci (perhaps a new format), removal of cytochrome b mutations, and alteration of Kelch13 loci to better detect newly emerging resistance. The gene discussed is MT-CYB; the disease is malaria.